Gülhan, R. Et Al. 2022. Pharmacokinetic characterization of favipiravir in patients with COVID-19.. British journal of clinical pharmacology , vol.88, no.7 , 3516-3522.

Gülhan, R., Eryüksel, E., Gülçebi İdriz Oğlu, M., Çulpan, Y., Toplu, A., Kocakaya, D., ... Tigen, E.(2022). Pharmacokinetic characterization of favipiravir in patients with COVID-19.. British journal of clinical pharmacology , vol.88, no.7, 3516-3522.

Gülhan, REZZAN Et Al. "Pharmacokinetic characterization of favipiravir in patients with COVID-19.," British journal of clinical pharmacology , vol.88, no.7, 3516-3522, 2022

Gülhan, REZZAN Et Al. "Pharmacokinetic characterization of favipiravir in patients with COVID-19.." British journal of clinical pharmacology , vol.88, no.7, pp.3516-3522, 2022

Gülhan, R. Et Al. (2022) . "Pharmacokinetic characterization of favipiravir in patients with COVID-19.." British journal of clinical pharmacology , vol.88, no.7, pp.3516-3522.

@article{article, author={REZZAN GÜLHAN Et Al. }, title={Pharmacokinetic characterization of favipiravir in patients with COVID-19.}, journal={British journal of clinical pharmacology}, year=2022, pages={3516-3522} }